Experts associated with Mater Research published in the Journal of Clinical Oncology their findings about cannabidiol oil.
According to the study, cannabidiol oil does not provide therapeutic effects for affective symptoms, quality of life, and pain.
The effects of cannabidiol oil was studied among 144 patients residing in Europe.
“There was no detectable effect of CBD on quality of life, depression, or anxiety. Adverse events did not differ significantly between arms apart from dyspnea that was more common with CBD,” the authors mentioned in their findings.
“Most participants reported feeling better or much better at days 14 (53% CBD and 65% placebo) and 28 (70% CBD and 64% placebo).”
“CBD oil did not add value to the reduction in symptom distress provided by specialist palliative care alone.”